Proteinase requirements of epidermal growth factor-induced ovarian cancer cell invasion

International Journal of Cancer

Volumn 78, Issue 3, 1998, Pages 331-337

  Ellerbroek, Shawn M ^a   Hudson, Laurie G ^b,c   Stack, M Sharon ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b UNIVERSITY OF NEW MEXICO   (United States)

^c UNIVERSITY OF NEW MEXICO HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; GELATINASE B; MATRIX METALLOPROTEINASE INHIBITOR; PROTEINASE; UROKINASE;

ARTICLE; CANCER GROWTH; CANCER INVASION; CELL MIGRATION; ENZYME ACTIVITY; ENZYME REGULATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; OVARY CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION;

CHEMOTAXIS; COLLAGEN; COLLAGENASES; CULTURE MEDIA, CONDITIONED; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INDUCTION; EPIDERMAL GROWTH FACTOR; FEMALE; GELATINASES; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; METALLOENDOPEPTIDASES; NEOPLASM INVASIVENESS; OVARIAN NEOPLASMS; PLASMINOGEN ACTIVATOR INHIBITOR 1; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TUMOR CELLS, CULTURED; URINARY PLASMINOGEN ACTIVATOR;

EID: 0032578691     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19981029)78:3<331::AID-IJC13>3.0.CO;2-9     Document Type: Article

References (25)

1. ANDREASON, P.A., KJOLLER, L., CHRISTENSEN, L. and DUFFY, M.J., The urokinase-type plasminogen activator system in cancer metastasis: a review. Int. J. Cancer, 72, 1-22 (1997).
2. AUERSPERG, N., MACLAREN, I.A. and KRUK, P.A., Ovarian surface epithelium: autonomous production of connective tissue-type extracellular matrix. Biol. Reprod., 44, 717-724 (1991).
3. BARTLETT, J.M. and 12 OTHERS, The prognostic value of epidermal growth factor mRNA expression in primary ovarian cancer. Brit. J. Cancer, 73, 301-306 (1996).
4. BAST, R.C., JR., JACOBS, I. and BERCHUCK, A., Malignant transformation of ovarian epithelium. J. nat. Cancer Inst., 52, 5322-5328 (1992).
5. BENBOW, U. and BRINCKERHOFF, C.E., The AP-1 site and MMP gene regulation: what is all the fuss about? Matrix Biol., 15, 519-526 (1997).
6. BERNHARD, E.J., BRUBER, S. and MUSCHEL, R.J., Direct evidence linking MMP-9 (92 kDa gelatinase/collagenase) expression to the metastatic phenotype in transformed rat embryo cells. Proc. nat. Acad. Sci. (Wash.), 91, 4293-4297 (1994).
7. CHA, D., O'BRIEN, P., O'TOOLE, E., WOODLEY, D. and HUDSON, L.G., Enhanced modulation of keratinocyte motility by transforming growth factor (TGF)-alpha relative to epidermal growth factor (EOF). J. invest. Dermatol., 106, 590-597 (1996).
8. CHAMBERS, S.K., WANG, Y., GERTZ, R.E. and KACINSKI, B.M., Macrophage colony stimulating factor mediates invasion of ovarian cancer cells through urokinase. Cancer Res., 55, 1578-1585 (1995).
9. CZERNOBUSKY, B., MOLL, R., LEVY, R. and FRANKE, W.W., Co-expression of cytokeratin and vimentin filaments in mesothelial. granulosa and rete ovarii cells of the human ovary. Europ. J. Cell Biol., 37, 175-190 (1985).
10. ECCLES, S.A., MODJTAHEDI, H., Box, G., COURT, W., SANDLE, J. and DEAN, C.J., Significance of the c-erbB family of receptor tyrosine kinases in metastatic cancer and their potential as targets for immunotherapy. Invasion Metastasis, 14, 337-348 (1995).
11. HIMELSTEIN, B.P., CANETE-SOLER, R., BERNHARD, E.J., DILKS, D.W. and MUSCHEL, R.J., Metalloproteinases in tumor progression: the contribution of MMP-9. Invasion Metastasis, 14, 246-258 (1995).
12. HOSONO, T., ITO, A., SATO, T., NAGASE, H. and MORI. Y., Translational augmentation of pro-matrix metalloproteinase 3 (prostromelysin 1) and tissue inhibitor of metalloproteinases (TIMP)-l induced by epidermal growth factor in human uterine cervical fibroblast. FEBS Lett., 381, 115-118 (1996).
13. MATRISIAN, L.M. and HOGAN, B.L., Growth factor-regulated proteases and extracellular matrix remodeling during mammalian development. Curr. Topics Develop. Biol., 24, 219-259 (1990).
14. MEDEN, H., MARX, D., RATH, W., KRON, M., FATTAHI-MEIBODK A., HINNEY, B. KUHN, W. and SCHAUER, A., Overexpression of the oncogene c-erbB2 in primary ovarian cancer: evaluation of the prognostic value in a Cox proportional hazards multiple regression. Int. J. Gynecol. Palhol., 13, 45-53 (1994).
15. MIGNATTI, P. and RIFKIN, D., Biology and biochemistry of proteinases in tumor invasion. Physiol. Rev., 73, 161-195 (1993).
16. MIRSHAHI, S.S., LOUNES, K.C., Lu, H., PUJADE-LAURAINE, E., MISHAL, Z., BENARD, J., BERNADOU, A., SORIA, C. and SORIA, J., Defective cell migration in an ovarian cancer cell line is associated with impaired urokinase-induced tyrosine phosphorylation. FEBS Lett., 411, 322-326 (1997).
17. MOSER, T.L., Pizzo, S.V., BAFETTI, L.M., FISHMAN, D.A. and STACK, M.S., Evidence for preferential adhesion βof ovarian carcinoma cells to type I collagen mediated by the α21 integrins. Int. J. Cancer, 67, 695-701 (1996).
18. MOSER, T.L.,YOUNG, T.N., RODRIGUEZ, G.C., Pizzo, S.V., BAST, R.C. and STACK, M.S., Secretion of extracellular matrix-degrading proteinases is increased in epithelial ovarian carcinoma. Int. J. Cancer, 56, 552-559 (1994).
19. OTTENSMEIER, C., SWANSON, L., STROBEL, T., DRUKER. B., NILOFF, J. and CANNISTRA, S.A., Absence of constitutive EGF receptor activation in ovarian cancer cell lines. Brit. J. Cancer, 74, 446-452 (1996).
20. PAPPOT, H., GARDSVOLL, H., ROMER, J., PEDERSEN, A.N., GRONDAHL-HANSEN, J., PYKE, C. and BRUNNER, N., Plasminogen activator inhibitor type 1 in cancer: therapeutic and prognostic implications. Biol. Chem. Hoppe-Seyler, 376, 259-267 (1995).
21. PIQUETTE, G.N., CRABTREE, M.E., EL-DANASOURI, I., MILKI, A. and POLAN, M.L., Regulation of plasminogen activator inhibitor-1 and -2 messenger ribonucleic acid levels in human cumulus and granulosa-luteal cells. J. clin. Endocrinol Metab., 76, 518-523 (1993).
22. STACK, M.S., ELLERBROEK, S.M. and FISHMAN, D.A., The role of proteolytic enzymes in the pathology of epithelial ovarian carcinoma. Int. J. Oncol., 12, 569-576 (1998).
23. STACK, M.S., GRAY, R.D. and Pizzo, S.V., Modulation of murine B16F10 melanoma plasminogen activator production by a synthetic peptide derived from laminin Achain. Cancer Res., 53, 1998-2004 (1993).
24. YOUNG, T.N., RODRIGUEZ, G.C., MOSER, T.L., BAST, R.C., Pizzo, S.V. and STACK, M.S., Coordinate expression of urinary-type plasminogen activator and its receptor accompanies malignant transformation of the ovarian surface epithelium. Amer. J. Obstet. Gynecol., 170, 1285-1296 (1994).
25. YOUNG, T.N., RODRIGUEZ. G.C., RINEHART, A.R., BAST, JR., R.C., Pizzo, S.V. and STACK, M.S., Characterization of gelatinases linked to extracellular matrix invasion in ovarian adenocarcinoma: purification of matrix metalloproteinase 2. Gynecol. Oncol., 62, 89-99 (1996).